NHI Price Revision in April Will Hit Drug Companies Hard: Mr Fujiyama of FPMAJ

In an interview with PHARM JAPAN on February 22, Akira Fujiyama, FPMAJ president, presented his views on the FY2002 NHI price system reform and the revision of medical fees and stressed that the 6.3% reduction in the next NHI price...read more